3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Tuberous Sclerosis
5
Seizures
4
Marijuana Abuse
3
Colonic Neoplasms
3
Breast Neoplasms
3
Sturge-Weber Syndrome
2
Nausea
2
Lennox Gastaut Syndrome
2
Glioblastoma
2
Epilepsies, Myoclonic
2
Anxiety Disorders
2
Vomiting
1
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Solid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parasomnias
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Multiple Myeloma
1
Liver Neoplasms
1
Liver Cirrhosis
1
Gallbladder Neoplasms
1
Epilepsy
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Colorectal Neoplasms
1
Interventions
Docetaxel
277
Prednisone
237
enzalutamide
177
Leuprolide
172
Radiotherapy
164
Abiraterone Acetate
154
Magnetic Resonance Spectroscopy
147
bicalutamide
137
Goserelin
134
Androgen Antagonists
111
Radiosurgery
101
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
100
apalutamide
79
abiraterone
77
gallium 68 PSMA-11
74
Specimen Handling
67
darolutamide
58
Gonadotropin-Releasing Hormone
58
Radiation
56
Triptorelin Pamoate
53
cabazitaxel
50
Zoledronic Acid
49
pembrolizumab
48
Radiotherapy, Intensity-Modulated
47
Flutamide
47
Brachytherapy
47
luprolide acetate gel depot
46
Standard of Care
45
Carboplatin
44
Estramustine
43
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Prostatic Neoplasms
×
Cannabidiol
×
Clear all
NCT07549256
2026-04-24
ProCan
Regionshospital Nordjylland
Phase 2
Not yet recruiting
58 enrolled